AXNA vs GNTA: Side-by-Side Comparison
Compare Amplifon S.p.A (AXNA) and Genenta Science SpA (GNTA) side by side: market cap EUR 2.62B vs USD 40.58M. Financials, growth and model signals on Bullrun.
| Metric | AXNA | GNTA |
|---|---|---|
| Company | Amplifon S.p.A | Genenta Science SpA |
| Country / Exchange | Italy · F | Italy · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Medical Distribution | Biotechnology |
| Market cap | EUR 2.62B | USD 40.58M |
| P/E ratio | 31.8 | — |
| Dividend yield | 2.94% | — |
| Valuation model | 28.1% overvalued | — |
| Revenue (latest FY) | EUR 2.40B | — |
| Revenue growth YoY | -0.6% | — |
| Net income | EUR 91.55M | — |
| Gross margin | — | — |
| Diluted EPS | 0.40 | — |